AT281280B - Verfahren zur Herstellung einer Masern-Vaccine - Google Patents

Verfahren zur Herstellung einer Masern-Vaccine

Info

Publication number
AT281280B
AT281280B AT812866A AT812866A AT281280B AT 281280 B AT281280 B AT 281280B AT 812866 A AT812866 A AT 812866A AT 812866 A AT812866 A AT 812866A AT 281280 B AT281280 B AT 281280B
Authority
AT
Austria
Prior art keywords
producing
measles vaccine
measles
vaccine
Prior art date
Application number
AT812866A
Other languages
German (de)
English (en)
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of AT281280B publication Critical patent/AT281280B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT812866A 1965-08-28 1966-08-26 Verfahren zur Herstellung einer Masern-Vaccine AT281280B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB83486A DE1247548B (de) 1965-08-28 1965-08-28 Verfahren zur Herstellung einer Masern-Vaccine

Publications (1)

Publication Number Publication Date
AT281280B true AT281280B (de) 1970-05-11

Family

ID=6981993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT812866A AT281280B (de) 1965-08-28 1966-08-26 Verfahren zur Herstellung einer Masern-Vaccine

Country Status (9)

Country Link
AT (1) AT281280B (enrdf_load_stackoverflow)
BE (1) BE686101A (enrdf_load_stackoverflow)
BR (1) BR6682416D0 (enrdf_load_stackoverflow)
CH (1) CH484277A (enrdf_load_stackoverflow)
DE (1) DE1247548B (enrdf_load_stackoverflow)
DK (2) DK119938B (enrdf_load_stackoverflow)
FR (2) FR1502631A (enrdf_load_stackoverflow)
GB (1) GB1161414A (enrdf_load_stackoverflow)
NL (1) NL6611851A (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211843A (en) * 1977-11-30 1980-07-08 L'institut Armand-Frappier Strain of measles virus and process of producing the same
CN104498446B (zh) * 2014-12-15 2017-03-15 北京科兴生物制品有限公司 一种在疫苗生产中灭活病毒的方法

Also Published As

Publication number Publication date
FR5666M (enrdf_load_stackoverflow) 1968-01-02
CH484277A (de) 1970-01-15
FR1502631A (fr) 1967-11-24
DK121811B (da) 1971-12-06
BE686101A (enrdf_load_stackoverflow) 1967-02-28
DE1247548B (de) 1967-08-17
NL6611851A (enrdf_load_stackoverflow) 1967-03-01
GB1161414A (en) 1969-08-13
DK119938B (da) 1971-03-15
BR6682416D0 (pt) 1973-12-04

Similar Documents

Publication Publication Date Title
CH515117A (de) Verfahren zur Herstellung einer Holzspanplatte
CH471186A (de) Verfahren zur Herstellung eines Kondensates
AT283283B (de) Verfahren zur Herstellung einer Kollagen-Dispersion
CH476037A (de) Verfahren zur Herstellung einer Beschichtungsmasse
AT267180B (de) Verfahren zur Herstellung einer wärmestabilen Zusammensetzung
CH467850A (de) Verfahren zur Herstellung einer fluidisierbaren Polyepoxydzubereitung
AT264716B (de) Verfahren zur Herstellung einer neuen Arzneimittelform
CH482758A (de) Verfahren zur Herstellung einer Polymerlösung
CH520341A (de) Verfahren zur Herstellung einer Streuscheibe
CH503786A (de) Verfahren zur Herstellung einer Emaille-Zubereitung
CH468061A (de) Verfahren zur Herstellung einer Schichtstruktur
AT284605B (de) Verfahren zur Herstellung einer Gelierhilfe
CH453934A (de) Verfahren zur Herstellung einer wurstartigen Verpackung
CH488792A (de) Verfahren zur Herstellung einer Beschichtungslösung
CH504425A (de) Verfahren zur Herstellung neuer Bisnorcholanderivate
AT315495B (de) Verfahren zur Herstellung einer Formmasse
CH549954A (de) Verfahren zur herstellung einer stabilen emulsion.
AT282821B (de) Verfahren zur Herstellung einer antigenfreien Vaccine
AT277460B (de) Verfahren zur Herstellung einer Tetanus-Vaccine
CH544121A (de) Verfahren zur Herstellung einer wasserlöslichen komplexen Assoziation
AT261770B (de) Verfahren zur Herstellung einer Leuchtmasse
AT265517B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
AT281280B (de) Verfahren zur Herstellung einer Masern-Vaccine
CH494984A (de) Verfahren zur Herstellung einer Ätzreserve
AT279642B (de) Verfahren zur Herstellung einer wasserunlöslichen Kollagenverbindung

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee